Return to High Altitude After Recovery from Coronavirus Disease 2019

Abstract

Luks, Andrew M. and Colin K. Grissom. Return to high altitude after recovery from coronavirus disease 2019. High Alt Med Biol. 00:000-000, 2021.-With the increasing availability of coronavirus disease 2019 vaccines and the eventual decline in the burden of the disease, it is anticipated that all forms of tourism, including travel to high altitude, will rebound in the near future. Given the physiologic challenges posed by hypobaric hypoxia at high altitude, it is useful to consider whether high-altitude travel will pose risks to those previously infected with severe acute respiratory syndrome coronavirus 2, particularly those with persistent symptoms after resolution of their infection. Although no studies have specifically examined this question as of yet, available data on the cardiopulmonary sequelae of COVID-19 provide some sense of the problems people may face at high altitude and who warrants evaluation before such endeavors. On average, most individuals who have recovered from COVID-19 have normal or near normal gas exchange, pulmonary function testing, cardiovascular function, and exercise capacity, although a subset of individuals have persistent functional deficits in some or all of these domains when examined up to 5 months after infection. Evaluation is warranted before planned high-altitude travel in individuals with persistent symptoms at least 2 weeks after a positive test or hospital discharge as well as in those who required care in an intensive care unit or suffered from myocarditis or arterial or venous thromboembolism. Depending on the results of this testing, planned high-altitude travel may need to be modified or even deferred pending resolution of the identified abnormalities. As more people travel to high altitude after the pandemic and further studies are conducted, additional data should become available to provide further guidance on these issues.

Wilderness Medical Society Clinical Practice Guidelines for the Prevention, Diagnosis, and Treatment of Acute Altitude Illness: 2024 Update

“…Depending on the results of these tests, individuals may need to modify or defer their high altitude travel plans. 139…”

The Actual Situation of Covid-19 Infection at High Altitudes in Perú

“…The COVID-19 pandemic in Perú has brought serious consequences to health, society, and the economy. The prevalence was so high that it caused the collapse of the health system, making it necessary to improvise increase the number of hospitalization and ICU beds, and the utilization of new strategies to bring recovery patients back to high altitudes [50].…”

Understanding Acute Respiratory Distress Syndrome in High-Altitude Environments: A Comprehensive Review of Diagnosis and Treatment

“…The PaO 2 /FiO 2 ratio can increase by 20% after treatment in the prone position during ECMO, and oxygenation in the patients can still be continuously improved after changing to the supine position [ 55 ]. The continuation of PPV therapy after 7 days of ECMO therapy also results in more pronounced improvements in patient oxygenation [ 55 , 56 ]. However, the relevant literature does not mention the impact on the improvement of long-term oxygenation in patients with ARDS.…”